Open Access
| Numéro |
Med Sci (Paris)
Volume 36, Numéro 6-7, Juin–Juillet 2020
m/s / COVID-19
|
|
|---|---|---|
| Page(s) | 555 - 558 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2020106 | |
| Publié en ligne | 19 juin 2020 | |
- Coronaviridae study group of the international committee on taxonomy of V. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5 : 536–44. [CrossRef] [PubMed] [Google Scholar]
- Tratner I. SRAS : 1. Le virus. Med Sci (Paris) 2003 ; 19 : 885–891. [CrossRef] [Google Scholar]
- Lee EYP, Ng MY, Khong PL. COVID-19 pneumonia: what has CT taught us? Lancet Infect Dis 2020; 20 : 384–5. [CrossRef] [PubMed] [Google Scholar]
- Jager S, Cimermancic P, Gulbahce N, et al. Global landscape of HIV-human protein complexes. Nature 2011 ; 481 : 365–370. [PubMed] [Google Scholar]
- James JS. Saquinavir (Invirase): first protease inhibitor approved–reimbursement, information hotline numbers. AIDS Treatment News 1995 ; 1–2. [Google Scholar]
- Hurst M, Faulds D. Lopinavir. Drugs 2000; 60 : 1371–9; discussion 80–1. [CrossRef] [PubMed] [Google Scholar]
- Capeau J, Caron M, Vigouroux C, et al. Les lipodystrophies secondaires aux traitements antirétroviraux de l’infection par le VIH. Med Sci (Paris) 2006 ; 22 : 531–536. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000 ; 356 : 1423–1430. [CrossRef] [PubMed] [Google Scholar]
- Ravaud C, Pare M, Azoulay S, et al. Impairment of the activin A autocrine loop by lopinavir reduces self-renewal of distinct human adipose progenitors. Sci Rep 2017 ; 7 : 2986. [CrossRef] [PubMed] [Google Scholar]
- Ravaud C, Paré M, Yao X, et al. Resveratrol and HIV-protease inhibitors control UCP1 expression through opposite effects on p38 MAPK phosphorylation in human adipocytes. J Cell Physiol 2019 ; 235 : 1184–1196. [Google Scholar]
- Vernochet C, Azoulay S, Duval D, et al. Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines. J Biol Chem 2005 ; 280 : 2238–2243. [CrossRef] [PubMed] [Google Scholar]
- Djedaini M, Peraldi P, Drici MD, et al. Lopinavir co-induces insulin resistance and ER stress in human adipocytes. Biochem Bioph Res Co 2009 ; 386 : 96–100. [CrossRef] [Google Scholar]
- Hilgenfeld R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 2014 ; 281 : 4085–4096. [CrossRef] [PubMed] [Google Scholar]
- Zhang L, Lin D, Sun X, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors. Science 2020; 368 : 409–12. [Google Scholar]
- Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003 ; 300 : 1763–1767. [Google Scholar]
- Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020; 382 : 1787–99. [Google Scholar]
- Lapatto R, Blundell T, Hemmings A, et al. X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature 1989 ; 342 : 299–302. [PubMed] [Google Scholar]
- Juckel D, Dubuisson J, Belouzard S. Les coronavirus, ennemis incertains. Med Sci (Paris) 2020, 36: 633–41. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.